Advertisement
Screener

STREAMEX CORP. (STEX) Overview

STREAMEX CORP. (STEX) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.08; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.27; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.47; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.74; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.55$0.90$1.49$2.45$4.03$6.632025-09-292026-09-29$0.24$0.67$1.87$5.24$14.71$41.262021-09-292026-09-29$0.24$0.83$2.91$10.16$35.54$124.322016-09-292026-09-29$0.24$0.83$2.91$10.16$35.54$124.322014-10-312026-09-29$0.24$0.83$2.91$10.16$35.54$124.322014-10-312026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$0.68
Previous close
$0.70
Change
-$0.03
Change (%)
-4.11%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

STEX
-77.61%
S&P 500
(m)

1 year

STEX
-87.60%
S&P 500
(m)

3 years

STEX
-86.13%
S&P 500
(m)

5 years

STEX
-97.58%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.08

-0.82-0.59-0.36-0.130.1031 Mar 2025: estimate (m); actual -0.1431 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.7430 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.4730 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.2731 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.0830 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.08(m)(m)
1 Jan 202631 Mar 2026(m)-0.27(m)(m)
1 Jul 202530 Sept 2025(m)-0.47(m)(m)
1 Apr 202530 Jun 2025(m)-0.74(m)(m)
1 Jan 202531 Mar 2025(m)-0.14(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -9.65

-9.73-7.44-5.15-2.86-0.5731 Dec 2022: estimate (m); actual -6.3331 Dec 2022(m)31 Dec 2023: estimate (m); actual -3.9531 Dec 2023(m)31 Dec 2024: estimate (m); actual -0.7531 Dec 2024(m)31 Dec 2025: estimate (m); actual -9.6531 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-9.65(m)(m)
1 Jan 202431 Dec 2024(m)-0.75(m)(m)
1 Jan 202331 Dec 2023(m)-3.95(m)(m)
1 Jan 202231 Dec 2022(m)-6.33(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 0.15M ■ Earnings -14.55M — Profit margin -9967.12%

-52.31M-389109.3%-32.95M-262728.3%-13.59M-136347.2%5.77M-9966.1%31 Mar 2024: revenue 0.01M; earnings -3.40M; profit margin -24300.00%31 Mar 202430 Jun 2024: revenue 0.01M; earnings -3.92M; profit margin -30115.38%30 Jun 202431 Mar 2026: revenue 0.01M; earnings -46.69M; profit margin -389108.33%31 Mar 202630 Jun 2026: revenue 0.15M; earnings -14.55M; profit margin -9967.12%30 Jun 2026

31 Dec 2024 ■ Revenue 0.04M ■ Earnings -10.33M — Profit margin -25825.00%

-35.80M-161339.9%-22.43M-109972.1%-9.05M-58604.2%4.32M-7236.4%31 Dec 2021: revenue 0.44M; earnings -31.92M; profit margin -7237.41%31 Dec 202131 Dec 2022: revenue 0.29M; earnings -27.05M; profit margin -9458.74%31 Dec 202231 Dec 2023: revenue 0.02M; earnings -29.04M; profit margin -161338.89%31 Dec 202331 Dec 2024: revenue 0.04M; earnings -10.33M; profit margin -25825.00%31 Dec 2024

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$0.68(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$0.68High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning STEX

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-500.83M
Profit margin
(m)
Return on assets · 12 month
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
1.15M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-16.75%*
Total return · month
-12.44%*
Total return · quarter
-15.19%*
Total return · half year
-43.93%*
Total return · year to date
-77.61%*
Total return · 1 year
-87.60%*
Total return · 3 years
-86.13%*
Total return · 5 years
-97.58%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

STREAMEX CORP. Overview

View more →

(m)

(m)

SEC CIK
1530766
Industry (SIC)
3845 Electromedical & Electrotherapeutic Apparatus
Country of operation
United States
Business address
165 LINCOLN AVE 2ND FLOOR, WINTER PARK, Florida, 32789, United States
Fiscal year end
1231
Phone
(203) 409-5444

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
IRIDEX CORP (IRIX)United States$0.011B
ENDRA Life Sciences Inc. (NDRA)United States$0.009B